Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Rapidly is the MicroRNA Market Expected to Expand Between 2025 and 2034 Based on Current Trends?
In recent years, the microrna market has seen rapid expansion. It’s expected to balloon from $1.33 billion in 2024 to $1.58 billion in 2025, marking a compound annual growth rate (CAGR) of 18.9%. The substantial growth seen in the historical span can be credited to several factors, including the discovery of microRNAs, the exploration of RNA interference (RNAi), various genome sequencing projects, advancements in computational biology and bioinformatics, and research into extracellular vehicles (EVs).
The forecast for the microrna market indicates a swift expansion in the size over the upcoming years, expected to reach $3.11 billion by 2029, with a compound annual growth rate (CAGR) of 18.5%. The projected growth during the forecast period is due to factors such as clinical translation, the establishment of regulatory networks and systems biology, the development of microRNA-centered therapies, potential therapeutic contributions, and the discovery of biomarkers. The period is also anticipated to see major trends like technological advancements, bioinformatics and data analytics, cross-species conservation, interaction within microbiomes and the study of functional mechanisms.
What Strategic Factors Are Influencing the Accelerated Growth of the MicroRNA Market?
The surge in cancer incidences is predicted to stimulate the expansion of the microRNA market. Cancer is a complex disease typified by unregulated cell development and proliferation, frequently resulting in malignant tumors that can penetrate nearby tissues and metastasize to distant organs, posing significant health hazards. The rise in cancer cases can be attributed to multiple factors, including aging demographics, lifestyle choices such as tobacco use and unhealthy eating habits, environmental toxins, and improved diagnostic techniques leading to early detection. Traditional cancer treatments are augmented with microRNA to increase drug susceptibility and enhance results. In addition to treatment, miRNAs function as diagnostic and prognostic biomarkers, assisting in the identification of specific cancer types, predicting disease advancement, and tracking therapeutic responses. For example, the National Cancer Institute, a US government agency, reported in May 2024 that roughly 20 million new cases and 9.7 million cancer-related deaths were recorded annually in 2022. Projections show that by 2040, there would be 15.3 million deaths and 29.9 million new incidences per year. Consequently, the surge in cancer incidences is fuelling the expansion of the microRNA market.
Explore Comprehensive Insights Into The Global MicroRNA Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp
Which Key Players Are Shaping the Future of the MicroRNA Market?
Major companies operating in the MicroRNA market are:
• Thermo Fisher Scientific Inc._x000D_
• Merck KGaA_x000D_
• Agilent Technologies Inc._x000D_
• Kaneka Corporation_x000D_
• Illumina Inc._x000D_
How Are the Latest Trends Influencing the Growth of the MicroRNA Market?
Leading companies in the microRNA market are placing emphasis on developing sophisticated solutions such as MiRNA probe customization services. These services are geared towards fulfilling the unique requirements of clinicians and researchers, improving the precision of miRNA detection, and supporting an array of applications. MiRNA probe customization services are specific provisions by biotechnology and molecular biology firms that create and supply personalized probes unique to certain microRNAs (miRNAs) for a variety of clinical and research uses. For instance, Abnova Corporation, a biotech firm based in Taiwan, in September 2023, introduced improved services for customizing miRNA probes, along with a fresh assortment of cataloged miRNA probes, aiming to cater to the varied needs of academic, industrial, and miRNA research-based communities. These probes are crucial in pinpointing and accurately locating miRNAs, small non-coding RNA molecules crucial for numerous biological functions. The customization services from Abnova guarantee high specificity and minimal cross-reactivity, rendering them ideal for examining samples with limited miRNA content.
Secure Your Global MicroRNA Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report
Which Key Segments Stand Out in Understanding the Composition of the MicroRNA Market?
The microrna market covered in this report is segmented –
1) By Products: Instruments, Consumables
2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays
3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications
4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations
Subsegments:
1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers
2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits
What Regions Are At the Forefront of MicroRNA Market Expansion?
North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the MicroRNA Market Classified and Defined in Market Analysis?
MicroRNAs are small, non-coding RNA molecules, typically about 20-22 nucleotides in length, used to regulate gene expression. They function by binding to complementary sequences on messenger RNA (mRNA) molecules, usually resulting in gene silencing through translational repression or target degradation.
Browse Through More Similar Reports By The Business Research Company:
Physical Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report
Mycoplasma Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report
Antiphospholipid Syndrome Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
